Artesunate is an antimalarial drug indicated for the emergency treatment of severe and/or complicated malaria caused by Plasmodium falciparum.
Artesunate is an antimalarial indicated for the emergency treatment of severe and/or complicated malaria caused by Plasmodium falciparum..
Given by intravenous or intramuscular injection as prescribed
Artesunate can be administered by intravenous (IV) or Intramuscular (IM)
The duration of treatment is at least one day, and will be determined by the health care provider.
The recommended dose is 2.4 mg per kg body weight at time 0,12 and 24 hours and subsequently every 24 hours
The recommended dose for children weighing 20 kg or more as for adults is: 2.4 mg per kg body weight.
The recommended dose for children weighing less than 20 kg is 3 mg per kg body weight.
Common Side Effects:
Nausea, vomiting, dizziness
Store below 25°C, protect from light
For use under medical supervision only. Not recommended for prophylaxis.
After at least 24 hours (3 doses) switch to oral therapy as soon as possible. To minimize the chance of recrudescence it is important that you are treated with an antimalarial drug for 7 consecutive days.